Liothyronine Sodium
NDC 87063-080, Liothyronine Sodium, tablet, from ASCLEMED USA INC..
- Product NDC
- 87063-080
- Status
- Listed
- Labeler
- ASCLEMED USA INC.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA200295
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/87063-080 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LIOTHYRONINE SODIUM5 ug/1
Pharmacologic classes
Triiodothyronine [CS]; l-Triiodothyronine [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 87063-080-00 | 87063008000 | 1000 TABLET in 1 BOTTLE (87063-080-00) |
| 87063-080-01 | 87063008001 | 100 TABLET in 1 BOTTLE (87063-080-01) |
| 87063-080-30 | 87063008030 | 30 TABLET in 1 BOTTLE (87063-080-30) |
| 87063-080-60 | 87063008060 | 60 TABLET in 1 BOTTLE (87063-080-60) |
| 87063-080-90 | 87063008090 | 90 TABLET in 1 BOTTLE (87063-080-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/26cf6872-f4d4-41dd-8957-a000f13efbb3
Use it
Look up 87063-080 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/87063-080 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 87063-080. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.